ArticleFrontiers in immunology2026
Human macrophages activate a coordinated program linking inflammation and cell death in response to intracellular Poly(I:C).
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Macrophages sense viral double-stranded RNA (dsRNA) via the innate immune receptors TLR3 and MDA5 whose activation drives a robust inflammatory program, often coupled to cell death. TLR3/TRIF-dependent apoptosis has been described in response to dsRNA. Growing evidence suggests that dsRNA may trigger multiple forms of cell death with mechanisms yet to be elucidated. In addition to TLR/TRIF axis, the necroptosis regulator RIPK3 has been implicated in both inflammatory response and cell death during viral infections in several cell types. However, its role in regulating these two events in human macrophages remains unclear. Methods: Here, we investigated in human monocyte-derived macrophages (hMDMs) the mechanisms of dsRNA induced cell death and its temporal and molecular linkage to inflammatory signaling, with a focus on the interplay between RIPK3 and the TLR3/TRIF pathways. Results: We found that intracellular Poly(I:C), a synthetic analogue of dsRNA, induced cell death with apoptotic and necroptotic features. TRIF-mediated signaling cascade and RIPK3 jointly contributed to caspase-8 activation leading to apoptosis. RIPK3 also promoted necroptosis by inducing MLKL phosphorylation. Downstream of caspases, Poly(I:C) induced cleavage of Gasdermin E (GSDME), which remained intracellular and localized in mitochondria contributing to the amplification of caspase-3 activation. RIPK3-dependent signaling drove the release of IFN-β and TNF-α and promoted the upregulation of the sensors TLR3 and MDA5, thereby amplifying the inflammatory axis. The inflammatory response preceded cell death, with RIPK3 being the key regulator of the early signaling and TLR3/TRIF becoming involved at later timepoints. Conclusions: Collectively, these findings identify RIPK3 as key mediator coordinating dsRNA-induced inflammatory signaling and regulated cell death in human macrophages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.